Showing results (181-190 of 211) with videos related to
Sort By:
Pageof 22
Digestive Surgery|August 1, 2023
Impact of Sarcopenic Obesity on Severe Postoperative Complications in Patients with Gastric Cancer Undergoing GastrectomyShunsuke Yamagishi, Yukiyasu Okamura, Woodae Kang, et al.International Journal of Oncology|September 6, 2014
Clinical utility of PDSS2 expression to stratify patients at risk for recurrence of hepatocellular carcinomaMitsuro Kanda, Hiroyuki Sugimoto, Shuji Nomoto, et al.Journal of Gastroenterology|September 1, 2014
Dihydropyrimidinase-like 3 is a putative hepatocellular carcinoma tumor suppressorHisaharu Oya, Mitsuro Kanda, Hiroyuki Sugimoto, et al.Liver Cancer|October 9, 2025
Tumor Mutational Burden as a Prognostic Biomarker for Relapse-Free Survival in Hepatocellular Carcinoma: Insights from Long-Term Follow-UpYuya Miura, Yukiyasu Okamura, Keiichi Ohshima, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 24, 2025
Surgery Versus Ablation for Hepatocellular Carcinoma: A Randomized Controlled Trial (SURF-RCT Trial) and a Nonrandomized Prospective Observational Trial (SURF-Cohort Trial)Yoshikuni Kawaguchi, Kiyoshi Hasegawa, Kosuke Kashiwabara, et al.Surgery Today|July 31, 2024
The KRAS G12D mutation increases the risk of unresectable recurrence of resectable colorectal liver-only metastasisKai Chen, Yukiyasu Okamura, Keiichi Hatakeyama, et al.Annals of Surgical Oncology|October 14, 2025
Comparison of Familial and Sporadic Pancreatic Cancer: Clinicopathological and Genomic FeaturesYuya Miura, Sumiko Ohnami, Keiichi Ohshima, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|May 13, 2026
Tumor Mutational Concordance and Recurrence Timing in Hepatocellular CarcinomaYuya Miura, Ryo Ashida, Keiichi Ohshima, et al.BMC Cancer|October 5, 2022
Overview and clinical significance of multiple mutations in individual genes in hepatocellular carcinomaTaisuke Imamura, Yukiyasu Okamura, Keiichi Ohshima, et al.Annals of Surgical Oncology|July 1, 2015
Reduced Expression of Adherens Junctions Associated Protein 1 Predicts Recurrence of Hepatocellular Carcinoma After Curative HepatectomyKazuhiro Ezaka, Mitsuro Kanda, Hiroyuki Sugimoto, et al.Pageof 22